Premium
Making veterinary medicines available in Europe
Publication year - 2008
Publication title -
veterinary record
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.261
H-Index - 99
eISSN - 2042-7670
pISSN - 0042-4900
DOI - 10.1136/vr.163.9.258
Subject(s) - agency (philosophy) , authorization , unit (ring theory) , government (linguistics) , veterinary medicine , bureaucracy , medicine , nightmare , political science , business , law , psychology , politics , sociology , computer security , social science , linguistics , philosophy , mathematics education , computer science , psychiatry
Obtaining authorisations for new medicines in Europe can be a bureaucratic nightmare, especially when seeking approval across several countries. In 1995, the European Medicines Agency ( emea ) was formed with the aim of reducing red tape and helping drug manufacturers cope with the differing regulations of the (now 27) eu member states. Grainger Laffan talked to Dr David Mackay, head of the veterinary medicines and inspections unit of the emea , at his office in Canary Wharf in London, where this practising veterinary surgeon turned researcher, turned government agency executive, has headed the unit for the past two years and is seeking new ways to streamline the authorisation process.